2C
LUNG icon

272 Capital’s Pulmonx LUNG Stock Holding History

272 Capital’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,730
Closed -$47.5K – 65
2024
Q3 		$47.5K Buy
+5,730
New +$41.5K 0.03% 58

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

272 Capital's LUNG Position: Q4 2024 in Review

272 Capital sold out of Pulmonx (LUNG) in Q4 2024, closing a stake of 5,730 shares — an estimated $47.5K sold.

272 Capital first reported a position in LUNG in Q3 2024 and held it in 1 quarter. The position peaked at $47.5K in Q3 2024. 118 funds tracked by Wall St. Rank hold LUNG as of Q4 2024.

  • 272 Capital reported no remaining Pulmonx position as of Q4 2024 after selling out during the quarter.
  • 272 Capital sold 5,730 Pulmonx shares in Q4 2024, an estimated $47.5K.
  • 272 Capital first reported a position in Pulmonx in Q3 2024 and held it in 1 quarter.
  • 272 Capital's Pulmonx position peaked at $47.5K in Q3 2024.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q4 2024.

Based on 272 Capital's 13F filing for Q4 2024, filed 14 Feb 2025.